Professor Chuanyuan Li received his bachelor’s degree from the University of Science and Technology of China, his Ph.D. in Cancer Biology from Harvard University, and his postdoctoral studies at Harvard. He worked as an Assistant Professor, Associate Professor, and Full Professor at Duke University School of Medicine in the United States beginning in 1997. He served as a lifelong professor in Cancer Biology, Pharmacology, and Dermatology and was the Deputy Director of Research in the Dermatology Department.

Now Professor Li is Distinguished Investigator and Director of Chinese Institute for Molecular and Cellular Therapeutics, Chinese Institutes for Medical Research, Beijing. Over the years, he has been involved in research on the mechanisms of tumor development, resistance mechanisms of tumors to radiation and chemotherapy, and the discovery of new molecular targets to enhance tumor immunotherapy. In these fields, he has achieved numerous innovative and impactful research results. He has over 150 peer-reviewed scholarly articles, many of which have appeared in prestigious journals such as Nature, Nature Medicine, Cell Stem Cell, and Molecular Cell, among others. Two innovative achievements in tumor immunotherapy from his research have entered the clinical trial phase.